256 related articles for article (PubMed ID: 25889801)
1. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
2. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
Chen CH; Chien CY; Huang CC; Hwang CF; Chuang HC; Fang FM; Huang HY; Chen CM; Liu HL; Huang CY
Oncogene; 2009 Jul; 28(30):2723-37. PubMed ID: 19525975
[TBL] [Abstract][Full Text] [Related]
3. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
[TBL] [Abstract][Full Text] [Related]
5. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
[TBL] [Abstract][Full Text] [Related]
6. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer.
Yang L; Zhou Q; Chen X; Su L; Liu B; Zhang H
Oncol Rep; 2016 Aug; 36(2):819-26. PubMed ID: 27373675
[TBL] [Abstract][Full Text] [Related]
7. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
8. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.
Chien CY; Tsai HT; Su LJ; Chuang HC; Shiu LY; Huang CC; Fang FM; Yu CC; Su HT; Chen CH
Oncotarget; 2014 Apr; 5(8):2243-62. PubMed ID: 24810160
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells.
Wang X; Lu N; Niu B; Chen X; Xie J; Cheng N
Mol Cancer Res; 2012 May; 10(5):588-96. PubMed ID: 22522455
[TBL] [Abstract][Full Text] [Related]
11. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
12. Tumor Suppressor miRNA-503 Inhibits Cell Invasion in Head and Neck Cancer through the Wnt Signaling Pathway via the WNT3A/MMP Molecular Axis.
Tang SJ; Fan KH; You GR; Huang SF; Kang CJ; Huang YF; Huang YC; Chang JT; Cheng AJ
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555553
[TBL] [Abstract][Full Text] [Related]
13. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer.
Chiu CC; Lin CY; Lee LY; Chen YJ; Lu YC; Wang HM; Liao CT; Chang JT; Cheng AJ
Clin Cancer Res; 2011 Jul; 17(14):4629-41. PubMed ID: 21642380
[TBL] [Abstract][Full Text] [Related]
14. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer.
Ahn MH; Kim JH; Choi SJ; Kim HJ; Park DG; Oh KY; Yoon HJ; Hong SD; Lee JI; Shin JA; Cho SD
Cell Oncol (Dordr); 2024 Apr; 47(2):497-511. PubMed ID: 37787967
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
17. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
[TBL] [Abstract][Full Text] [Related]
18. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway.
Chen CH; Lu PJ; Chen YC; Fu SL; Wu KJ; Tsou AP; Lee YC; Lin TC; Hsu SL; Lin WJ; Huang CY; Chou CK
Oncogene; 2007 Jun; 26(29):4272-83. PubMed ID: 17237822
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
[TBL] [Abstract][Full Text] [Related]
20. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
